| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| NUCLEagle Nuclear Energy Corp. | $215.49M | — | — | — | — | $28.28M | — | AI pending |
| HITIHigh Tide Inc. | $215.72M | — | CA$593.99M | +13.7% | -CA$50.75M | CA$47.88M | CA$28.09M | AI pending |
| GSHRGesher Acquisition Corp. II | $215.79M | 54.4× | — | — | — | $310.5K | — | AI pending |
| SPOKSpok Holdings, Inc | $215.88M | 17.8× | $139.71M | +1.5% | $15.88M | $16.59M | $0 | AI pending |
| SDSYASouth Dakota Soybean Processors Llc | $215.92M | 6.4× | $503.82M | -9.1% | $17.74M | $6.12M | $321M | AI pending |
| PEPGPepGen Inc. | $216.44M | — | — | — | — | $22.76M | — | AI pending |
| TPVGTriplePoint Venture Growth BDC Corp. | $216.58M | 5.4× | $90.93M | -16.3% | $49.21M | $14M | $440.2M | AI pending |
| TNXPTonix Pharmaceuticals Holding Corp. | $216.79M | — | $13.11M | +29.8% | -$124.02M | $176.23M | $7.49M | AI pending |
| BETRBetter Home & Finance Holding Co | $216.87M | — | $164.87M | +52.0% | -$165.87M | $102.25M | — | AI pending |
| CURVTorrid Holdings Inc. | $216.95M | — | $1B | -9.4% | -$7.03M | $22.84M | $268.37M | AI pending |
| KGEIKolibri Global Energy Inc. | $217.35M | 11.4× | $57.42M | -2.1% | $15.48M | $2.8M | $48.76M | AI pending |
| PTACPatriot Acquisition Corp. | $217.44M | — | — | — | — | $1.2M | — | AI pending |
| KROSKeros Therapeutics, Inc. | $218.1M | — | $244.06M | +6,775.0% | $87.01M | $257.61M | — | AI pending |
| CEPLCapstone Energy Plus, Inc. | $218.72M | — | $89.24M | +27.8% | $2.83M | $32.3M | $25.34M | AI pending |
| SIGASiga Technologies Inc | $219.14M | — | $94.57M | -31.8% | $23.28M | $117.58M | $0 | AI pending |
| BRCCBRC Inc. | $219.18M | — | $398.26M | +1.7% | -$11.91M | $12.03M | $31.61M | AI pending |
| GAMGGlobal Asset Management Group, Inc. | $219.2M | — | $95.31K | +1,806.2% | -$153.73K | $64.18K | — | AI pending |
| DERMJourney Medical Corp | $219.3M | — | $61.24M | +11.1% | -$11.43M | $25.64M | $25.47M | AI pending |
| FOTBFirst Ottawa Bancshares, Inc. | $219.34M | 8.1× | $11.46M | -2.4% | $750K | $11.42M | — | AI pending |
| ANTXAN2 Therapeutics, Inc. | $219.62M | — | — | — | — | $44.32M | — | AI pending |